Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
28,280 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...
A six-page FDA memo quietly opens the door for certain nicotine products to reach the market before complete regulato...
July brought mixed signals to the stock market today as entertainment stocks like AMC faced dilution concerns while t...
Airwallex launches a new billing product, letting merchants invoice customers, track software usage, and manage subsc...
CoreWeave stock is front and center as data-center demand rises. With a growing backlog and expanding capacity plans,...
A sharp move lower has investors asking if the lululemon stock just 52-week headlines reflect a durable change or a t...
A $28 billion AI hardware IPO is trading at about 7x forward earnings, sparking a heated debate: is it a disrupted, d...
Investing in memory chips means weighing volatility against opportunity. This article digs into could micron technolo...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
Analysts are scrutinizing Strategy’s STRC funding loop as the near-$100 par anchor tightens. A disruption could tempe...
Critics like the billionaire investor jeremy grantham call Bitcoin a mere speculative asset. This article argues why ...